Clinical Characteristics of Japanese Diabetic Patients with Critical Limb Ischemia Presenting Fontaine Stage IV

Overview

Journal Diabetol Int

Specialty Endocrinology

Date 2019 Jul 6

PMID 31275791

Citations 10

Authors

Mitsuyoshi Takahara

Osamu Iida

Yukihiro Fujita

Masakazu Haneda

Affiliations

Soon will be listed here.

Abstract

The aim of the current study was to reveal the clinical characteristics of Japanese diabetic patients with critical limb ischemia (CLI) presenting ischemic unhealed ulcer/gangrene (Fontaine stage IV) in the real-world settings. The current retrospective cross-sectional study included consecutive 282 Japanese diabetic patients who underwent endovascular therapy for CLI presenting Fontaine stage IV. The prevalence of diabetes-related complications was estimated adopting multiple imputation (50 times). The patients were aged 70 ± 10 years. Median duration of diabetes was 21 (interquartile range 12-31) years. The prevalence of proliferative diabetic retinopathy, end-stage renal disease on regular dialysis, stroke, coronary artery disease, and chronic heart failure was estimated at 48% (95% confidence interval 39-56%), 52% (46-58%), 34% (28-39%), 48% (42-54%), and 35% (29-41%), respectively. The prevalence of stroke, coronary artery disease, and chronic heart failure was not significantly associated with the duration of diabetes (all > 0.05). On the other hand, the prevalence of proliferative diabetic retinopathy and end-stage renal disease on regular dialysis was significantly positively associated with the duration of diabetes (both < 0.05). However, these prevalences reached as high as ~ 30% even in patients with duration of diabetes < 10 years. In conclusion, the advanced stage of diabetes-related complications was prevalent in patients with CLI presenting Fontaine stage IV.

Citing Articles

Diabetes mellitus and peripheral artery disease.

Takahara M Diabetol Int. 2025; 16(1):7-12.

PMID: 39877447 PMC: 11769882. DOI: 10.1007/s13340-024-00785-8.

Clinical practice of diabetic foot, nephropathy, and retinopathy in Japan: cross-sectional study using local and nationwide questionnaire surveys.

Fujita Y, Haneda M Diabetol Int. 2022; 13(3):493-502.

PMID: 35693993 PMC: 9174372. DOI: 10.1007/s13340-021-00559-6.

Diabetes Mellitus and Lower Extremity Peripheral Artery Disease.

Takahara M JMA J. 2021; 4(3):225-231.

PMID: 34414316 PMC: 8355746. DOI: 10.31662/jmaj.2021-0042.

Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia.

Jiang X, Yuan Y, Ma Y, Zhong M, Du C, Boey J J Diabetes Res. 2021; 2021:6699292.

PMID: 34046505 PMC: 8128546. DOI: 10.1155/2021/6699292.

Heterogeneity of Age and Its Associated Features in Patients with Critical Limb Ischemia.

Takahara M, Iida O, Soga Y, Kodama A, Terashi H, Suzuki K Ann Vasc Dis. 2021; 13(3):300-307.

PMID: 33384734 PMC: 7751078. DOI: 10.3400/avd.oa.20-00067.

References

Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T . Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res. 2002; 34(9):509-15. DOI: 10.1055/s-2002-34791. View

Nakagami T . Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia. 2004; 47(3):385-394. DOI: 10.1007/s00125-004-1334-6. View

Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M . Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005; 29(6):620-7. DOI: 10.1016/j.ejvs.2005.02.035. View

Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F . Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2006; 33 Suppl 1:S1-75. DOI: 10.1016/j.ejvs.2006.09.024. View

Yokoyama H, Kawai K, Kobayashi M . Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10). Diabetes Care. 2007; 30(4):989-92. DOI: 10.2337/dc06-1859. View

Uccioli L, Gandini R, Giurato L, Fabiano S, Pampana E, Spallone V . Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic. Diabetes Care. 2010; 33(5):977-82. PMC: 2858201. DOI: 10.2337/dc09-0831. View

Yokoyama H, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto H . Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20). Diabet Med. 2011; 28(10):1221-8. DOI: 10.1111/j.1464-5491.2011.03347.x. View

Tsuboi S, Miyauchi K, Kasai T, Ogita M, Dohi T, Miyazaki T . Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention. Circ J. 2012; 77(2):456-61. DOI: 10.1253/circj.cj-12-0730. View

Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T . The impact of predisposing factors on long-term outcome after stroke in diabetic patients: the Fukuoka Stroke Registry. Eur J Neurol. 2013; 20(6):921-7. DOI: 10.1111/ene.12100. View

10.

Kawasaki S, Misawa H, Tamura Y, Kondo Y, Satoh S, Hasegawa O . Relationship between coronary artery disease and retinopathy in patients with type 2 diabetes mellitus. Intern Med. 2013; 52(22):2483-7. DOI: 10.2169/internalmedicine.52.9444. View

11.

Lejay A, Georg Y, Tartaglia E, Gaertner S, Geny B, Thaveau F . Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2013; 28(4):983-9. DOI: 10.1016/j.avsg.2013.08.026. View

12.

Ueki K, Sasako T, Kato M, Okazaki Y, Okahata S, Katsuyama H . Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial. BMJ Open Diabetes Res Care. 2016; 4(1):e000123. PMC: 4731753. DOI: 10.1136/bmjdrc-2015-000123. View

13.

Hayashino Y, Izumi K, Okamura S, Nishimura R, Origasa H, Tajima N . Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3). J Diabetes Investig. 2016; 8(2):243-249. PMC: 5334313. DOI: 10.1111/jdi.12550. View

14.

Noronen K, Saarinen E, Alback A, Venermo M . Analysis of the Elective Treatment Process for Critical Limb Ischaemia with Tissue Loss: Diabetic Patients Require Rapid Revascularisation. Eur J Vasc Endovasc Surg. 2016; 53(2):206-213. DOI: 10.1016/j.ejvs.2016.10.023. View

15.

Freisinger E, Malyar N, Reinecke H, Lawall H . Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis. Cardiovasc Diabetol. 2017; 16(1):41. PMC: 5379505. DOI: 10.1186/s12933-017-0524-8. View

16.

Iida O, Takahara M, Soga Y, Kodama A, Terashi H, Azuma N . Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia). Circ Cardiovasc Interv. 2017; 10(12). PMC: 5753823. DOI: 10.1161/CIRCINTERVENTIONS.117.005531. View

17.

Meloni M, Izzo V, Giurato L, Del Giudice C, Da Ros V, Cervelli V . Recurrence of Critical Limb Ischemia After Endovascular Intervention in Patients with Diabetic Foot Ulcers. Adv Wound Care (New Rochelle). 2018; 7(6):171-176. PMC: 5994148. DOI: 10.1089/wound.2017.0778. View

18.

Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y . Japanese Clinical Practice Guideline for Diabetes 2016. Diabetol Int. 2019; 9(1):1-45. PMC: 6224875. DOI: 10.1007/s13340-018-0345-3. View

19.

Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K . Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes. 1996; 45 Suppl 3:S14-6. DOI: 10.2337/diab.45.3.s14. View